Diagnosis of IBD was achieved by measuring levels of the TRIM31 protein or mRNA in patient intestinal epithelial samples and comparing with control samples, while screening drugs would focus on comparing the expression of TRIM31 when administered or not administered.106. The gene discussed is TRIM31; the disease is inflammatory bowel disease.